查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型
市场调查报告书
商品编码
1420138

南美洲和中美洲类器官市场预测至 2030 年 - 区域分析 - 按器官类型、应用、来源和类型

South & Central America Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type
出版日期: | 出版商: The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

南美洲和中美洲类器官市场预计将从2022年的1.3238亿美元成长到2030年的6.5425亿美元。预计2022年至2030年CAGR为22.1%。

专注于药物发现活动推动南美洲和中美洲类器官市场

对新药和先进药物不断增长的需求正在推动药物发现和研究的整体步伐。根据 ClinicalTrials.gov 统计，2020 年临床试验研究总数估计为 356,282 项。休布雷希特研究所最近的一项调查表明，类器官可以透过识别不太可能从该药物中受益的患者来使昂贵的药物更具成本效益。全球范围内越来越多的临床试验预计将推动对先进医疗技术（包括类器官模型）的需求。

此外，药物发现中的类器官不仅限于癌症，它们还用于其他疾病，例如囊性纤维化、多囊性肾病变、小头畸形以及肠道和气道传染病。例如，类器官可以概括器官的特性，例如器官结构和功能。此外，类器官可以恢復组织或器官的原始遗传和表观遗传状态，使它们适合基因编辑。各种研究显示了将 CRISPR-Cas9 技术与类器官结合的积极成果，这为囊性纤维化的突破提供了更多机会。根据2020 年发表的一项研究“基于CRISPR 的腺嘌呤编辑器纠正囊性纤维化类器官生物库中的无义突变”，囊性纤维化类器官生物库代表了664 名患者，其中约20%理论上能够有效修復无义突变透过腺嘌呤碱基编辑器在囊性纤维化跨膜导体受体中。儘管基因编辑类器官在一些动物模型中取得了一些成果，但其效率明显较低，成功率不高。因此，研究和开发基因编辑类器官的安全性、长期稳定性和功能性的方法至关重要。

此外，COVID-19 大流行引发了开发人类肺类器官模型的需求。例如，MilliporeSigma 开发了 3dGRO 人类肺类器官培养系统，使研究人员能够控制、存取和复製器官组织，以培养人类肺上皮类器官模型，从而有助于在研究过程中获得积极和成功的结果。因此，此类创新预计将为市场成长提供更重要的成长机会。

南美洲和中美洲类器官市场概述

南美洲和中美洲类器官市场分为巴西、阿根廷以及南美洲和中美洲其他地区。由于癌症病例数量的增加、政府措施的不断增加以及类器官研究和开发的不断增加，该地区的市场预计将增长。

南美洲及中美洲类器官市场收入及 2030 年预测（百万美元）

南美洲和中美洲类器官市场细分

南美洲和中美洲类器官市场分为器官类型、类型、应用、来源和国家。

依器官类型，南美洲和中美洲类器官市场分为肠、肝、胃、胰臟、肺、脑、肾等。 2022 年，肠道部分在南美洲和中美洲类器官市场中占据最大份额。

根据类型，南美洲和中美洲类器官市场分为仪器、消耗品和服务。 2022 年，消耗品领域在北美类器官市场中占据最大份额。

根据应用，南美洲和中美洲类器官市场分为发育生物学疾病、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。 2022 年，发育生物学疾病领域在南美洲和中美洲类器官市场中占据最大份额。

根据来源，南美洲和中美洲类器官市场分为多能干细胞和器官特异性成体干细胞。 2022 年，多能干细胞细分市场在南美洲和中美洲类器官市场中占有较大份额。

根据国家/地区，南美洲和中美洲类器官市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲类器官市场占据主导地位。

Cellesce、InSphero、Merck KGaA、STEMCELL Technologies Inc 和 Thermo Fisher Scientific Inc 是南美洲和中美洲类器官市场的一些领先公司。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 南美洲和中美洲的主要见解
  • 南美洲和中美洲市场吸引力

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲类器官市场模式

  • 概述
  • 南美洲和中美洲 PEST 分析

第 5 章：南美洲和中美洲类器官市场 - 主要产业动态

  • 主要市场驱动因素：
    • 对肿瘤建模和生物样本库的需求不断增长
    • 越来越多地采用个人化药物
    • 人们日益关注开发动物测试模型的替代方案
  • 主要市场限制：
    • 与将类器官纳入现有工作流程相关的问题
    • 缺乏熟练的专业人员
  • 主要市场机会：
    • 专注于药物发现活动
  • 未来的趋势：
    • 将类器官与器官晶片结合
  • 影响分析：

第 6 章：类器官市场 - 南美洲与中美洲市场分析

  • 南美洲和中美洲类器官市场收入，2022 - 2030

第 7 章：南美洲和中美洲类器官市场 - 2030 年收入和预测 - 按器官类型。

  • 概述
  • 2022 年和 2030 年南美洲和中美洲类器官市场收入份额，按器官类型划分（%）
  • 胃
  • 肠
  • 肝
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：南美洲和中美洲类器官市场 - 收入和 2030 年预测 -按应用。

  • 概述
  • 2022 年和 2030 年南美洲和中美洲类器官市场收入份额（按应用划分）
  • 发育生物学
  • 传染病的疾病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：南美洲和中美洲类器官市场 - 收入和 2030 年预测 - 按来源。

  • 概述
  • 2022 年和 2030 年南美洲和中美洲类器官市场收入份额（按来源划分）
  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：南美洲和中美洲类器官市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 南美洲和中美洲类器官市场收入份额，按类型 2022 年和 2030 年 (%)
  • 仪器
  • 耗材
  • 服务

第 11 章：南美洲和中美洲类器官市场 - 国家分析

    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：COVID-19 前后的影响

  • COVID-19 前后的影响

第 13 章：南美洲和中美洲类器官市场产业格局

  • 概述
  • 市场上公司采取的成长策略，(%)
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：南美洲和中美洲类器官市场，主要公司概况

  • STEMCELL Technologies Inc.
  • Cellesce Ltd
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • InSphero

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: BMIRE00028764

The South & Central America organoids market is expected to grow from US$ 132.38 million in 2022 to US$ 654.25 million by 2030. It is estimated to grow at a CAGR of 22.1% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel South & Central America Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

South & Central America Organoids Market Overview

The South & Central America organoids market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for organoids.

South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Organoids Market Segmentation

The South & Central America organoids market is segmented into organ type, type, application, Source, and country.

Based on organ type, the South & Central America organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the South & Central America organoids market in 2022.

Based on type, the South & Central America organoid market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the North America organoid market in 2022.

Based on application, the South & Central America organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the South & Central America organoids market in 2022.

Based on source, the South & Central America organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held the larger share of the South & Central America organoids market in 2022.

Based on country, the South & Central America organoids market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America organoids market in 2022.

Cellesce, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc, are some of the leading companies operating in the South & Central America organoids market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America organoids market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South America organoids market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the organoids market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 South & Central America Key Insights
  • 2.2 South & Central America Market Attractiveness

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Organoids Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis

5. South & Central America Organoids Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Growing Adoption of Personalized Drugs
    • 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
  • 5.2 Key Market Restraints:
    • 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
    • 5.2.2 Dearth of Skilled Professionals
  • 5.3 Key Market Opportunities:
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends:
    • 5.4.1 Combining Organoid with Organ-On-A-Chip
  • 5.5 Impact Analysis:

6. Organoids Market - South & Central America Market Analysis

  • 6.1 South & Central America Organoids Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Organ Type.

  • 7.1 Overview
  • 7.2 South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Intestine
    • 7.4.1 Overview
    • 7.4.2 Intestine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Liver
    • 7.5.1 Overview
    • 7.5.2 Liver: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pancreas
    • 7.6.1 Overview
    • 7.6.2 Pancreas: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Lung
    • 7.7.1 Overview
    • 7.7.2 Lung: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Brain
    • 7.8.1 Overview
    • 7.8.2 Brain: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Kidney
    • 7.9.1 Overview
    • 7.9.2 Kidney: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Developmental Biology
    • 8.3.1 Overview
    • 8.3.2 Developmental Biology: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Disease Pathology of Infectious Disease
    • 8.4.1 Overview
    • 8.4.2 Disease Pathology of Infectious Disease: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Regenerative Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Drug Toxicity and Efficacy Testing
    • 8.6.1 Overview
    • 8.6.2 Drug Toxicity and Efficacy Testing: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Drug Discovery and Personalized Medicine
    • 8.7.1 Overview
    • 8.7.2 Drug Discovery and Personalized Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Source.

  • 9.1 Overview
  • 9.2 South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • 9.3 Pluripotent Stem Cells
    • 9.3.1 Overview
    • 9.3.2 Pluripotent Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Organ-specific Adult Stem Cells
    • 9.4.1 Overview
    • 9.4.2 Organ-specific Adult Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Organoids Market - Revenue and Forecast to 2030 - by Type

  • 10.1 Overview
  • 10.2 South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • 10.3 Instruments
    • 10.3.1 Overview
    • 10.3.2 Instruments: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Consumables
    • 10.4.1 Overview
    • 10.4.2 Consumables: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Services
    • 10.5.1 Overview
    • 10.5.2 Services: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Organoids Market - Country Analysis

  • 11.1 South & Central America Organoids Market: Overview
    • 11.1.1 South & Central America Organoids Market by Country
      • 11.1.1.1 Brazil
        • 11.1.1.1.1 Overview
        • 11.1.1.1.2 Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.1.3 Brazil Organoids Market, by Organ Type
        • 11.1.1.1.4 Brazil Organoids Market, by Application
        • 11.1.1.1.5 Brazil Organoids Market, by Source
        • 11.1.1.1.6 Brazil Organoids Market, by Type
      • 11.1.1.2 Argentina
        • 11.1.1.2.1 Overview
        • 11.1.1.2.2 Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.2.3 Argentina Organoids Market, by Organ Type
        • 11.1.1.2.4 Argentina Organoids Market, by Application
        • 11.1.1.2.5 Argentina Organoids Market, by Source
        • 11.1.1.2.6 Argentina Organoids Market, by Type
      • 11.1.1.3 Rest of South & Central America
        • 11.1.1.3.1 Overview
        • 11.1.1.3.2 Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.1.3.3 Rest of South & Central America Organoids Market, by Organ Type
        • 11.1.1.3.4 Rest of South & Central America Organoids Market, by Application
        • 11.1.1.3.5 Rest of South & Central America Organoids Market, by Source
        • 11.1.1.3.6 Rest of South & Central America Organoids Market, by Type

12. Pre & Post COVID-19 Impact

  • 12.1 Pre & Post COVID-19 Impact

13. South & Central America Organoids Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. South & Central America Organoids Market, Key Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Cellesce Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 InSphero
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Organoids Market Segmentation
  • Table 2. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 3. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 5. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 6. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 7. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 8. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 9. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 10. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Organ Type
  • Table 11. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 12. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Source
  • Table 13. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn) - Type
  • Table 14. Organic Developments Done by Companies
  • Table 15. Inorganic Developments Done by Companies
  • Table 16. Glossary of Terms, South & Central America Organoids Market

List Of Figures

  • Figure 1. South & Central America Organoids Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Organoids Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Organoids Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
  • Figure 7. Stomach: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Intestine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Liver: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pancreas: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Lung: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Brain: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Kidney: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. South & Central America Organoids Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Developmental Biology: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Disease Pathology of Infectious Disease: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Regenerative Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. South & Central America Organoids Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 23. Pluripotent Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Organ-specific Adult Stem Cells: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Organoids Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 26. Instruments: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Consumables: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Services: South & Central America Organoids Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South & Central America Organoids Market, By Country - Revenue (2022) ($Mn)
  • Figure 30. South & Central America Organoids Market, By Key Countries, 2022 and 2030 (%)
  • Figure 31. Brazil Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Argentina Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Rest of South & Central America Organoids Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Pre & Post COVID-19 Impact
  • Figure 35. Growth Strategies Done by the Companies in the Market, (%)